PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Wolfson Centre for Global Virus Research, University of Nottingham, A Floor, West Block, Queen\'s Medical Centre, Derby Road, Nottingham NG7 2UH, UK.\', \'NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Queen\'s Medical Centre, Derby Road, Nottingham NG7 2UH, UK.\', \'School of Life Sciences, University of Nottingham, A Floor, West Block, Queen\'s Medical Centre, Derby Road, Nottingham NG7 2UH, UK.\', \'Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool Science Park IC2, 146 Brownlow Hill, Liverpool L3 5RF, UK.\', \'School of Life Sciences, University of Nottingham, Life Sciences Building, University Park Campus, Nottingham NG7 2RD, UK.\', \'Injury, Inflammation & Recovery Sciences, School of Medicine, University of Nottingham, C Floor, West Block, Queen\'s Medical Centre, Derby Road, Nottingham NG7 2UH, UK.\', \'Trauma and Orthopaedics, University Hospitals Nottingham, C Floor, West Block, Queen\'s Medical Centre, Derby Road, Nottingham NG7 2UH, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/scitranslmed.abj0847
?:doi
?:hasPublicationType
?:journal
  • Science translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 34376569
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 9.7
?:rankingScore_hIndex
  • 147
is ?:relation_isRelatedTo_publication of
?:title
  • Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all